val-leu-arg-p-nitroanilide has been researched along with tosylarginine methyl ester in 1 studies
Studies (val-leu-arg-p-nitroanilide) | Trials (val-leu-arg-p-nitroanilide) | Recent Studies (post-2010) (val-leu-arg-p-nitroanilide) | Studies (tosylarginine methyl ester) | Trials (tosylarginine methyl ester) | Recent Studies (post-2010) (tosylarginine methyl ester) |
---|---|---|---|---|---|
28 | 0 | 0 | 197 | 2 | 18 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bittar, ER; Figueiredo, AF; Maia, CN; Miranda, TL; Santoro, MM; Sousa, MO | 1 |
1 other study(ies) available for val-leu-arg-p-nitroanilide and tosylarginine methyl ester
Article | Year |
---|---|
Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N
Topics: Catalysis; Chromogenic Compounds; Humans; Hydrolysis; Kallikreins; Kinetics; Models, Chemical; Oligopeptides; Protein Binding; Substrate Specificity; Tosylarginine Methyl Ester | 2002 |